Evaluating Differences in Whole Blood, Serum, and Urine Screening Tests for Zika Virus, Puerto Rico, USA, 2016

Asher Y. Rosinger(Pennsylvania State University), Carrie K. Shapiro‐Mendoza(Emory University), Denise J. Jamieson(University of Iowa), Miguel Valencia‐Prado, Dana Meaney‐Delman(National Center for Emerging and Zoonotic Infectious Diseases), Caitlin Pedati(Centers for Disease Control and Prevention), Sascha Ellington(Centers for Disease Control and Prevention), Jennifer S. Read(Foundation for Human Potential), Lyle R. Petersen(Centers for Disease Control and Prevention), Carmen Deseda(Office of Readiness and Response), Betsy Schroeder(Centers for Disease Control and Prevention), Mary Goodwin(Office of Readiness and Response), Freddy A. Medina(Centers for Disease Control and Prevention), Margaret A. Honein(National Center on Birth Defects and Developmental Disabilities), Romeo R. Galang, Laura E. Adams(Centers for Disease Control and Prevention), Brenda Rivera-García(Centers for Disease Control and Prevention), Samantha M. Olson(National Center for Immunization and Respiratory Diseases), Janice Pérez‐Padilla, Candimar Colón(Centers for Disease Control and Prevention), Jorge L. Muñoz‐Jordán(Centers for Disease Control and Prevention), Gilberto A. Santiago(Centers for Disease Control and Prevention), Sonia Bakkour(University of California, San Francisco), Regina M. Simeone
Emerging infectious diseases
April 27, 2021
Cited by 1


Related Papers